Olanzapine and 5-HT3 With or Without Dexamethasone to Prevent CINV

Clinical trial NCT05805800 · COMPLETED

Trial details

NCT number: NCT05805800
Sponsor: Xingchen Peng
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chemotherapy-induced Nausea and Vomiting

Start date: 2023-04-15
Primary completion: 2024-04-30
Enrollment: 275

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.